docetaxel,pembrolizumab
Merck
['breast']
tremendous work by dr. differential impact of proliferation signature on efficacy of neoadjuvant chemoimmunotherapy in stil-enriched and stil-low triple-negative breast cancer (tbc) a true physician-scientist who makes a difference in the lab and clinic #asco23 
PhD @HopkinsMedicine / MD @MayoClinic / PGY3 @StanfordRadOnc / @StanfordCancer Fellow / #ASCOYIA / #NativeHawaiian / @KSNews ‘08  / COI: https://t.co/liUGlyKnQf / MyViews